Spots Global Cancer Trial Database for eflornithine hydrochloride
Every month we try and update this database with for eflornithine hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma | NCT03794349 | High Risk Neuro... Recurrent Neuro... Refractory Neur... | Dinutuximab Eflornithine Hy... Irinotecan Hydr... Sargramostim Temozolomide | 1 Year - | Children's Oncology Group | |
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma | NCT03794349 | High Risk Neuro... Recurrent Neuro... Refractory Neur... | Dinutuximab Eflornithine Hy... Irinotecan Hydr... Sargramostim Temozolomide | 1 Year - | Children's Oncology Group |